{"prompt": "['The VWDMin Trial', 'Version v1.0', 'Protocol PRO15070638', 'March 19, 2018', 'Doris M. Rubio, PhD is an Associate Vice Provost for Faculty Director, CHRC Data Center and Professor of', 'Medicine, Biostatistics, Nursing and Clinical and Translational Science at the University of Pittsburgh.', '49']['The VWDMin Trial', 'Version v1.0', 'Protocol PRO15070638', 'March 19, 2018', '10.3 ABBREVIATIONS', 'AE', 'Adverse Event', 'CCC', 'Clinical Coordinating Center', 'CCDC', 'Center for Clinical Trials and Data Coordination', 'CFR', 'Code of Federal Regulations', 'CMP', 'Clinical Monitoring Plan', 'CRF', 'Case Report Form', 'CRHC DC', 'Center for Health Care Data Center', 'DCC', 'Data Coordinating Center', 'DHHS', 'Department of Health and Human Services', 'DSMB', 'Data Safety Monitoring Board', 'eCRF', 'Electronic Case Report Forms', 'eSYSDM', 'Electronic System for Data Management', 'FDA', 'Food and Drug Administration', 'GCP', 'Good Clinical Practice', 'GLP', 'Good Laboratory Practices', 'GMP', 'Good Manufacturing Practices', 'GWAS', 'Genome-Wide Association Studies', 'HIPAA', 'Health Insurance Portability and Accountability Act', 'HTC', 'Hemophilia Treatment Center', 'IB', \"Investigator's Brochure\", 'ICH', 'International Conference on Harmonisation', 'IND', 'Investigational New Drug Application', 'IRB', 'Institutional Review Board', 'ITT', 'Intention-To-Treat', 'MOP', 'Manual of Procedures', 'NCT', 'National Clinical Trial', 'NIH', 'National Institutes of Health', 'NHLBI', 'National Institutes of Heart, Blood, Lung Institute', 'OHRP', 'Office for Human Research Protections', 'PI', 'Principal Investigator', 'QA', 'Quality Assurance', 'QC', 'Quality Control', 'rVWF', 'Recombinant Von Willebrand Factor', 'SAE', 'Serious Adverse Event', 'SAP', 'Statistical Analysis Plan', 'SOP', 'Standard Operating Procedure', 'TA', 'Tranexamic acid, Lysteda', 'UP', 'Unanticipated Problem', 'US', 'United States', 'VNA', 'Visiting Nurses Association', 'VWD', 'Von Willebrand Disease', 'VWDMin', 'Von Willebrand Disease Minimize Trial', 'VWF', 'Von Willebrand Factor', '50']['The VWDMin Trial', 'Version v1.0', 'Protocol PRO15070638', 'March 19, 2018', '10.4 PROTOCOL AMENDMENT HISTORY', 'The table below is intended to capture changes of IRB-approved versions of the protocol, including a', 'description of the change and rationale. A Summary of Changes table for the current amendment is', 'located in the Protocol Title Page.', 'Version', 'Date', 'Description of Change', 'Brief Rationale', '51']\n\n###\n\n", "completion": "END"}